¿Cuál es la utilidad de la prueba cardiopulmonar del ejercicio en pacientes con síndrome pos-COVID-19?
Barra lateral del artículo
Contenido principal del artículo
##plugins.themes.bootstrap3.displayStats.downloads##
Detalles del artículo
Sección
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-CompartirIgual 4.0.
Cómo citar
Referencias
- Albouaini K, Egred M, Alahmar A, et al. Cardiopulmonary exercise testing and its application. Postgrad Med J. 2007; 83(985):675-82.
- Balady GJ, Arena R, Sietsema K, et al. Clinician’s Guide to cardiopulmonary exercise testing in adults: a scientific statement from the American Heart Association. Circulation. 2010; 122(2):191-
- Carfì A, Bernabei R, Landi F, et al. Gemelli Against COVID-19 Post-Acute Care Study Group. Persistent Symptoms in Patients After Acute COVID-19. JAMA. 2020;324(6):603-5.
- Clavario P, De Marzo V, Lotti R, et al. Assessment of functional capacity with cardiopulmonary exercise testing in nonsevere COVID-19 patients at three months follow-up. doi: https://doi. org/10.1101/2020.11.15.20231985
- Dorelli G, Braggio M, Gabbiani D, et al. Importance of Cardiopulmonary Exercise Testing amongst Subjects Recovering from COVID-19. Diagnostics (Basel). 2021;11(3):507.
- Guazzi M, Bandera F, Ozemek C, et al. Cardiopulmonary Exercise Testing: What Is its Value? J Am Coll Cardiol. 2017;70(13):1618-36.
- Guazzi M, Adams V, Conraads V, et al. Clinical recommendations for cardiopulmonary exercise testing data assessment in specific patient populations. Eur Heart J. 2012; 33(23):2917-27.
- Herdy AH, Ritt LE, Stein R, et al. Cardiopulmonary Exercise Test: Background, Applicability and Interpretation. Arq Bras Cardiol. 2016; 107(5):467-81.